SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
May 02, 2024 16:23 ET
|
Pomerantz LLP
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). Such investors are advised to...
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 02, 2024 16:05 ET
|
Zymeworks Inc.
Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of...
Zymeworks Announces Participation in Upcoming Investor Conferences
April 30, 2024 06:00 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
April 24, 2024 15:28 ET
|
Pomerantz LLP
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). Such investors are advised...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
April 16, 2024 15:08 ET
|
Pomerantz LLP
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). Such investors are advised...
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 11, 2024 06:00 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
CARBIOS présente ses résultats annuels 2023 et confirme le calendrier 2024 de son déploiement industriel et commercial
April 11, 2024 00:45 ET
|
Carbios
Solide structure financière du Groupe CARBIOS : position de trésorerie de 192 millions d’euros au 31 décembre 2023Avancée de la construction, en France, de la première usine au monde de...
CARBIOS announces fiscal-year 2023 financial results and confirms 2024 calendar for industrial and commercial roll-out
April 11, 2024 00:45 ET
|
Carbios
CARBIOS Group’s solid financial structure: cash position of €192 million on December 31, 2023Construction progress of world’s first PET1 biorecycling plant in France: in line with delivery...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
April 08, 2024 15:08 ET
|
Pomerantz LLP
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). Such investors are advised...
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
April 08, 2024 06:00 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...